Drug
Advagraf
Advagraf: highest development phase Post-Market, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Advagraf NCT02432053 | Post-Market | Kidney Transplantation |
Latest
No recent events.
Follow Advagraf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.